Biolife solutions announces $73 million sale of its scisafe biostorage subsidiary

Strategic divestiture heightens focus on proprietary, higher-margin cell processing products all-cash transaction fortifies balance sheet bothell, wash. , nov. 12, 2024 /prnewswire/ --  biolife solutions , inc. (nasdaq: blfs) ("biolife" or the "company"), a leading developer and supplier of cell processing tools and services for the cell and gene therapy (cgt) market, announces the sale of its wholly owned biostorage subsidiary scisafe holdings, inc. ("scisafe") for $73 million in cash.
BLFS Ratings Summary
BLFS Quant Ranking